Mast Cell Inhibition for Diverse Applications Beyond BPH/LUTS
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of mast cell inhibition to address unmet needs in agriculture, environmental sustainability, aquaculture, veterinary medicine, and human skin health, demonstrating its versatility and broad applicability.
Background and Problem Solved
The original patent focused on treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) using mast cell inhibition. However, the potential of this technology extends far beyond these specific applications. This inventive concept tackles the limitations of the original patent by exploring new use cases and industries where mast cell inhibition can provide significant benefits.
Detailed Description of the Inventive Concept
The new claims showcase the adaptability of mast cell inhibition in various contexts. For instance, in agriculture, mast cell stabilizers and histamine receptor antagonists can be used to prevent histamine release in response to pest allergens, reducing crop damage. In environmental sustainability, mast cell inhibitors and histamine receptor antagonists can mitigate the effects of climate change on pollinator populations. Similarly, in aquaculture, this composition can reduce inflammation and improve water quality. In veterinary medicine, the system can treat respiratory diseases in companion animals, and in human skin health, topical compositions can reduce inflammation and improve skin barrier function.
Novelty and Inventive Step
The novelty of this inventive concept lies in its application of mast cell inhibition to entirely new industries and problem domains. The inventive step is the recognition of the broader potential of this technology and its adaptation to address unmet needs in diverse fields.
Alternative Embodiments and Variations
Alternative embodiments of this inventive concept could include using different types of mast cell inhibitors or histamine receptor antagonists, varying the composition or dosage, or exploring other modes of administration. Additionally, the concept could be extended to other industries or applications, such as cosmetics, textiles, or biotechnology.
Potential Commercial Applications and Market
This inventive concept has significant commercial potential across multiple industries, including agriculture, environmental sustainability, aquaculture, veterinary medicine, and human skin health. The market for these applications is substantial, with potential revenue streams from product sales, licensing, and partnerships.
Original Patent Information
| Patent Number | US 11,857,531 |
|---|---|
| Title | Combination mast cell inhibition for treatment of BPH/LUTS |
| Assignee(s) | Northwestern University |